Our assessment
Bottom line
Harrison.ai CXR has a substantial multi-finding research base, but a broad headline result is not enough to characterize every supported finding. The most decision-relevant evidence is finding-specific, version-specific, and tied to the jurisdiction and workflow in which the product is used.
Based on public sources. RIR did not independently test this product. This is not an endorsement or recommendation.
What the evidence supports
Reviewed official materials establish a real chest X-ray analysis product used in multiple health systems.
What remains uncertain
Current-version performance by finding, population, equipment, and care setting remains outside this source-limited profile.
How it was studied
Annalise CXR, now represented as Harrison.ai CXR, has been evaluated with retrospective multicase datasets and reader studies across numerous chest X-ray findings. Regulatory availability and supported findings vary by market and version.